ICCC — IMMUCELL CORP /DE/
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 811641 ·
Last close
$11.33
Market Cap
$103.01M
52W High
$12.10
52W Low
$4.52
ADV30
12,498
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 8,039,951 | 3,555,060 | 957,770 | 952,510 | 47,958,262 | 7,914,406 | 15,184,077 |
| Jun 2026 | 7,186,113 | 2,437,222 | 1,934,934 | 1,834,656 | 46,629,796 | 8,860,205 | 15,255,260 |
| Mar 2026 | 10,357,295 | 4,657,444 | 1,969,316 | 1,941,607 | 44,108,374 | 6,812,637 | 14,973,334 |
| Dec 2025 | 7,625,999 | 2,910,209 | -57,956 | -2,849,142 | 42,532,447 | 3,806,831 | 15,476,967 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$5,892,060
Investing CF
$-1,660,499
Financing CF
$-1,369,850
CapEx
$-1,677,399
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.08
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-11,427,490
Inventory
$9,078,466
Receivables
$2,903,635
ST Investments
—
EBIT TTM
$1,250,560
Pretax Income TTM
$853,607
Interest Exp TTM
$396,953
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$30,675,528
EBITDA
$7,050,686
Free Cash Flow
$3,082,192
Enterprise Value
$96,407,384
Total Cash
$8,860,205
Total Debt
$12,447,535
Shares Out
9,091,361
Trailing EPS
$0.07
Book Value
$2.99
ROE
2.6%
ROA
6.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 27,644,174 | 1,649,305 | -1,040,027 | 42,532,447 | 15,476,967 | 27,055,480 | 2,475,292 |
| Dec 2024 | 26,493,169 | -1,640,159 | -2,156,629 | 45,100,477 | 17,582,290 | 27,518,187 | 357,903 |
| Dec 2023 | 17,471,669 | -5,748,078 | -5,774,598 | 43,808,102 | 18,815,025 | 24,993,077 | -4,674,236 |
| Dec 2022 | 18,567,962 | -2,298,943 | -2,493,805 | 44,860,649 | 14,480,600 | 30,380,049 | -1,543,871 |
TTM Snapshot
Revenues TTM
$30,675,528
NetIncome TTM
$787,373
OpCashFlow TTM
—
Assets (Latest)
$46,629,796
Forward EPS
$-0.11
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | $120.80M | $1.17 | — |
| NNNN | Anbio Biotechnology | $160.20M | $3.65 | — |
| IMDX | Insight Molecular Diagnostics Inc. | $58.25M | $1.78 | — |
| IBAC | IB Acquisition Corp. | $54.33M | $10.85 | — |
| ONMD | OneMedNet Corp | $293.47M | $4.95 | — |
News headlines (Yahoo Finance, 1h cache)
ImmuCell Corp (ICCC) Q3 2026 Earnings Call Highlights: 46% Sales Surge and Return to Profitability
2026-11-13 23:02 · Yahoo
ImmuCell (ICCC) Q3 2026 Earnings Call Transcript
2026-11-13 20:45 · Yahoo
ImmuCell Q3 Earnings Call Highlights
2026-11-13 16:14 · Yahoo
ImmuCell Corporation Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026
2026-11-12 21:05 · Yahoo
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026
2026-11-06 21:05 · Yahoo
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
2026-10-12 20:05 · Yahoo
ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
2026-08-20 22:45 · Yahoo
ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
2026-08-14 23:01 · Yahoo
ImmuCell Q2 Earnings Call Highlights
2026-08-14 14:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.